Phenotypic and Molecular Characterisation of Cerebral Amyloid Angiopathy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Phenotypic and Molecular Characterisation of Cerebral Amyloid Angiopathy — Stella

Recruiting

Back to Cerebral Amyloid Aβ Angiopathy trials

Trial locations(1 site)

France

University Hospital Rouen, Rouen

Key details

Sponsor

University Hospital, Rouen

Enrollment target

~100 participants

Started

March 2023

Primary completion

July 2027

Age range

18 Years – 99 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov